Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol

V.H.J. van der Velden; A. Sluijs-Geling; B.E.S. Gibson; J.G.T. Marvelde; P.G. Hoogeveen; W.C.J. Hop; K. Wheatley; M.B. Bierings; G.J. Schuurhuis; S.S.N. de Graaf; E.R. van Wering; J.J.M. van Dongen

doi:https://doi.org/10.1038/leu.2010.153

Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol

V.H.J. van der Velden, A. Sluijs-Geling, B.E.S. Gibson, J.G.T. Marvelde, P.G. Hoogeveen, W.C.J. Hop, K. Wheatley, M.B. Bierings, G.J. Schuurhuis, S.S.N. de Graaf, E.R. van Wering, J.J.M. van Dongen

Hematology laboratory (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

129 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1599-1606
Journal	Leukemia
Volume	24
Issue number	9
DOIs	https://doi.org/10.1038/leu.2010.153
Publication status	Published - 2010

Access to Document

https://doi.org/10.1038/leu.2010.153

Cite this

van der Velden, V. H. J., Sluijs-Geling, A., Gibson, B. E. S., Marvelde, J. G. T., Hoogeveen, P. G., Hop, W. C. J., Wheatley, K., Bierings, M. B., Schuurhuis, G. J., de Graaf, S. S. N., van Wering, E. R., & van Dongen, J. J. M. (2010). Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol. Leukemia, 24(9), 1599-1606. https://doi.org/10.1038/leu.2010.153

@article{71b833d6362c47c4bbd8cdbbee906740,

title = "Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol",

author = "{van der Velden}, V.H.J. and A. Sluijs-Geling and B.E.S. Gibson and J.G.T. Marvelde and P.G. Hoogeveen and W.C.J. Hop and K. Wheatley and M.B. Bierings and G.J. Schuurhuis and {de Graaf}, S.S.N. and {van Wering}, E.R. and {van Dongen}, J.J.M.",

year = "2010",

doi = "https://doi.org/10.1038/leu.2010.153",

language = "Undefined/Unknown",

volume = "24",

pages = "1599--1606",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "9",

}

van der Velden, VHJ, Sluijs-Geling, A, Gibson, BES, Marvelde, JGT, Hoogeveen, PG, Hop, WCJ, Wheatley, K, Bierings, MB, Schuurhuis, GJ, de Graaf, SSN, van Wering, ER & van Dongen, JJM 2010, 'Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol', Leukemia, vol. 24, no. 9, pp. 1599-1606. https://doi.org/10.1038/leu.2010.153

Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol. / van der Velden, V.H.J.; Sluijs-Geling, A.; Gibson, B.E.S. et al.
In: Leukemia, Vol. 24, No. 9, 2010, p. 1599-1606.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol

AU - van der Velden, V.H.J.

AU - Sluijs-Geling, A.

AU - Gibson, B.E.S.

AU - Marvelde, J.G.T.

AU - Hoogeveen, P.G.

AU - Hop, W.C.J.

AU - Wheatley, K.

AU - Bierings, M.B.

AU - Schuurhuis, G.J.

AU - de Graaf, S.S.N.

AU - van Wering, E.R.

AU - van Dongen, J.J.M.

PY - 2010

Y1 - 2010

U2 - https://doi.org/10.1038/leu.2010.153

DO - https://doi.org/10.1038/leu.2010.153

M3 - Article

C2 - 20668473

SN - 0887-6924

VL - 24

SP - 1599

EP - 1606

JO - Leukemia

JF - Leukemia

IS - 9

ER -